WuXi Biologics (Cayman) Inc. (WXXWY) Q2 2026 Earnings Call Transcript

WuXi Biologics to Conduct Up to $400 Million Share Buyback; Shares Up 4%

WuXi Biologics said it plans to buy back up to $400 million of its shares from the open market, according to a filing with the Hong Kong bourse.The company said its current share price does not...

Focus: China pharma projects disrupted by Sino-US tensions

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling supplies and discussing testing locally, said sources with knowledge of the matter, as they seek to mitigate the impact of U.S.-China trade tensions.

WuXi Biologics Aktie: Hoffnung auf mehr!

Der Biologika-Spezialist erhält zum achten Mal die Branchenauszeichnung und verzeichnet beachtliches Kurswachstum bei fortschreitender internationaler Expansion. WuXi Biologics hat erneut den CDMO ...

WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)

Merck to buy vaccine plant from WuXi Biologics: report

WuXi Firms Surge on Slimmer Chances of US Biosecure Passage

Shares of Chinese biotech service providers WuXi AppTec Co. and WuXi Biologics Cayman Inc. surged Monday, after a draft US legislation seeking to eliminate their linchpin role in global drug development missed its last big window for passage into law this year.

WuXi Biologics-Aktie kaum gefragt: Kurs bricht um 7,56 Prozent ein (1,8152 €)

Zu den großen Verlierern am Aktienmarkt zählt am Donnerstag die Aktie von WuXi Biologics . Der Titel verliert deutlich an Wert. Zu den größten Verlierern des Tages an der Börse zählt derzeit die Wu...

Chinese investors pile into Hong Kong stocks in stimulus buying frenzy

Alibaba, HKEX and Wuxi Biologics lead the way as net inflows blow past last year’s total in a buying rush ahead of the ‘golden week’ holiday.

WuXi Biologics: Consider Proposed Legislation And Financial Prospects

Democrat to vote against bill restricting Chinas WuXi Biologics, BGI By Reuters

Democrat to vote against bill restricting Chinas WuXi Biologics, BGI

WuXi Biologics (Cayman) Inc. (WXXWY) Q2 2024 Earnings Call Transcript

IRW-News: Medigene AG: Medigene und WuXi Biologics schließen Forschungskooperation für Off-the-Shelf TCR-gesteuerte T-Zell-Engager ab

IRW-PRESS: Medigene AG: Medigene und WuXi Biologics schließen Forschungskooperation für Off-the-Shelf TCR-gesteuerte T-Zell-Engager abPlanegg/Martinsried ( IRW-Press /08.08.2024) - Partnerschaft verbindet die führende Rolle von Medigene bei der Gener...

IRW-News: Medigene AG: Medigene und WuXi Biologics schließen Forschungskooperation für Off-the-Shelf TCR-gesteuerte T-Zell-Engager ab

IRW-PRESS: Medigene AG: Medigene und WuXi Biologics schließen Forschungskooperation für Off-the-Shelf TCR-gesteuerte T-Zell-Engager abPlanegg/Martinsried ( IRW-Press /08.08.2024)- Partnerschaft verbindet die führende Rolle von Medigene ...

Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers

Planegg/Martinsried, August 8, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and WuXi Biologics (stock code: 2269.HK) enter into a three-year, multi-target strategic partnership to design and co-research T cell receptor (TCR)-guided T Cell Engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors. The collaboration combines the respective expertise of each company with Medigene’s 3S (sensitive, specific and safe) TCR generation and characterization capabilities and WuXi Biolog...

WuXi Biologics Jumps on Hope Key US Sanction Bill May Hit Wall

Shares in WuXi Biologics Cayman Inc. surged the most in five months on speculation a US bill that can ban Chinese biotechnology firms from doing business may be excluded from the National Defense Authorization Act.

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the US$888 billion seen just over a decade earlier in 2010. Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies. Like all ETFs, pharmaceutical ETFs are a good option for those who want to trade a set of assets in the pharmaceutical industry instead of focusing solel...

WuXi Biologics: Staying On The Sidelines

WuXi Bio, AppTec Jump as Biosecure Act Leader Quits Congress

Shares of WuXi Biologics Cayman Inc. and its sister company WuXi AppTec Co. gained in Hong Kong after a US lawmaker sponsoring a bill that would block the companies from federal contracts said he will leave the House next month.